quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:00·367d
PRRelease
Dynavax Technologies Corporation logo
Moderna Inc. logo
Sanofi logo
+2

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

DVAX· Dynavax Technologies CorporationMRNA· Moderna Inc.SNY· SanofiTARS· Tarsus Pharmaceuticals Inc.GBT· Global Blood Therapeutics Inc.
Health Care
Original source

Companies

  • DVAX
    Dynavax Technologies Corporation
    Health Care
  • MRNA
    Moderna Inc.
    Health Care
  • SNY
    Sanofi
    Health Care
  • TARS
    Tarsus Pharmaceuticals Inc.
    Health Care
  • GBT
    Global Blood Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Apr 24TARSUpdateOppenheimer$98.00
  • Apr 20SNYUpdateBNP Paribas Exane$50.00
  • Feb 12SNYUpdateBofA Securities-
  • Jan 28MRNAUpdateBarclays$25.00
  • Jan 27SNYUpdateCitigroup-
  • Jan 16SNYUpdateUBS-

Related

  • ANALYST4h
    Oppenheimer resumed coverage on Tarsus Pharmaceuticals with a new price target
  • SEC1d
    SEC Form 6-K filed by Sanofi
  • NEWS2d
    Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate
  • NEWS3d
    Moderna Announces Data to be Presented at 2026 ASCO Annual Meeting
  • NEWS3d
    Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19
  • NEWS3d
    Moderna to Present at Upcoming Conferences in May 2026
  • ANALYST4d
    Sanofi downgraded by BNP Paribas Exane with a new price target
  • NEWS6d
    Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026 AACR Annual Meeting
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022